Journal of Pharmaceutical Research

The PDF file you selected should load here if your Web browser has a PDF reader plug-in installed (for example, a recent version of Adobe Acrobat Reader).

If you would like more information about how to print, save, and work with PDFs, Highwire Press provides a helpful Frequently Asked Questions about PDFs.

Alternatively, you can download the PDF file directly to your computer, from where it can be opened using a PDF reader. To download the PDF, click the Download link above.

Fullscreen Fullscreen Off


The development and utilization of Biotechnology-derived therapeutic products namely, recombinant DNA derived products emerges as the fastestgrowing segment in the pharmaceutical market. These products are larg  molecular weight and structurally complex molecules that are produced in living cells through genetic engineering. Biotechnology-derived therapeutic products are being developed over the past three decades and are under patent protection. The high cost of these therapeutic products has become a key issue in the battle concerning ever-increasing healthcare costs. The expiry of patent protection for biotechnology-derived therapeutic products of innovator origin has led to the development of Similar Biologics in India. Maintaining rapid as well as environmentally sustainable growth remains an important and achievable goal for India. In this concern, to meet unmet need and to append Make in India concept, pharmaceutical industry developed alternative similar biologics.
User
Notifications
Font Size